Trial Profile
Phase IV Study of the Effect of Nebulized Budesonide on Exhaled Nitric Oxide in Children, Four to Six Years of Age, With Asthma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 22 Jan 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 22 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Sep 2007 New trial record.